Anifrolumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Anifrolumab?
Monoclonal antibody
Source Human
Target interferon α/β receptor
Identifiers
CAS Registry Number 1326232-46-5
ATC code None
Chemical data
Formula C6444H9964N1712O2018S44
Molecular mass 145.12 kDa

Anifrolumab[1] is a monoclonal antibody designed for the treatment of systemic lupus erythematosus.[2]

This drug was developed by MedImmune.

References[edit]

  1. ^ World Health Organization (2013). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 109" (PDF). WHO Drug Information 27 (2). 
  2. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Anifrolumab, American Medical Association.